BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32664550)

  • 1. 5-(4
    Mavridis E; Bermperoglou E; Pontiki E; Hadjipavlou-Litina D
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32664550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazoles and Pyrazolines as Anti-Inflammatory Agents.
    Mantzanidou M; Pontiki E; Hadjipavlou-Litina D
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34198914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Arylidene-1-indandiones as Pleiotropic Agents with Antioxidant and Inhibitory Enzymes Activities.
    Kouzi O; Pontiki E; Hadjipavlou-Litina D
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31816866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of phenyl-substituted amides with antioxidant and anti-inflammatory activity as novel lipoxygenase inhibitors.
    Pontiki E; Hadjipavlou-Litina D
    Med Chem; 2007 Mar; 3(2):175-86. PubMed ID: 17348855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacochemical study of new Cu(II) complexes with thiophen-2-yl saturated and alpha,beta-unsaturated substituted carboxylic acids.
    Panagoulis D; Pontiki E; Skeva E; Raptopoulou C; Girousi S; Hadjipavlou-Litina D; Dendrinou-Samara C
    J Inorg Biochem; 2007 Apr; 101(4):623-34. PubMed ID: 17276511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
    El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
    Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors.
    Ali SA; Awad SM; Said AM; Mahgoub S; Taha H; Ahmed NM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):847-863. PubMed ID: 32216479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
    ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
    Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trioxsalen derivatives with lipoxygenase inhibitory activity.
    Hadjipavlou-Litina D; E Bariamis S; Militsopoulou M; Athanassopoulos CM; Papaioannou D
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1351-6. PubMed ID: 19912068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicoumarol derivatives: Green synthesis and molecular modelling studies of their anti-LOX activity.
    Simijonović D; Vlachou EE; Petrović ZD; Hadjipavlou-Litina DJ; Litinas ΚE; Stanković N; Mihović N; Mladenović MP
    Bioorg Chem; 2018 Oct; 80():741-752. PubMed ID: 30077781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
    Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
    Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Structure Activity Relationship (SAR), and Biological Activities of Benzylideneacetophenones Derivatives.
    Choudhary AN; Kumar A; Juyal V
    Antiinflamm Antiallergy Agents Med Chem; 2015; 14(3):172-82. PubMed ID: 26776971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA; Labib MB; Abdel-Latif M
    Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterocyclic aryl(phenyl)acetic Acid and aryl acetohydroxamic acids as antiinflammatory -antioxidant agents and inhibitors of lipoxygenase and serine proteases.
    Michaelidou A; Hadjipavlou-Litina D; Matsini I; Tsitsogianni E
    Med Chem; 2007 Sep; 3(5):439-45. PubMed ID: 17897068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of new C-10 substituted dithranol pleiotropic hybrids.
    Bariamis SE; Magoulas GE; Grafanaki K; Pontiki E; Tsegenidis T; Athanassopoulos CM; Maroulis G; Papaioannou D; Hadjipavlou-Litina D
    Bioorg Med Chem; 2015 Nov; 23(22):7251-63. PubMed ID: 26515039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity.
    Nandha B; Ramareddy SA; Kuntal H
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800030. PubMed ID: 29732612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel imidazolone derivatives as potential COX-2 inhibitors.
    Hassanein HH; Khalifa MM; El-Samaloty ON; El-Rahim MA; Taha RA; Magda ; Ismail MF
    Arch Pharm Res; 2008 May; 31(5):562-8. PubMed ID: 18481009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.